BACKGROUND: historically, stage i rectal cancer was treated with total mesorectal excision. however, there has been growing use of local excision, with and without adjuvant therapy, to treat these early rectal cancers. little is known about how patients and providers choose among the various treatment approaches.
t he use of transanal local excision (le) in the treatment of rectal cancer is increasing. 1 although this trend is appropriate for some patients with low-risk tumors, le alone leads to inferior oncologic outcomes in patients with higher-risk tumors. 2, 3 Reasons for the increase in le have not been explored previously.
total mesorectal excision (tme) alone has been and remains the standard of care for stage i rectal cancer and provides excellent oncologic outcomes with >90% overall survival. 4 however, factors other than oncologic outcomes may influence decision making regarding treatment. Presumably, transanal operations are chosen for their lower operative morbidity and potential for improved quality of life.
le is believed to have less impact on quality of life, with less possibility of permanent colostomy and less potential for short-and long-term bowel, bladder, and sexual dysfunction. 5 however, little is known about the decisionmaking process with various treatment approaches.
Previous studies have found that certain patient attributes are associated with higher participation in decision making for cancer care, such as younger age, better education, and better health. [6] [7] [8] Patients who are younger and less educated or patients who see higher-volume surgeons are less likely to have their actual roles match their preferred roles. 9 much of what is known comes from studies examining surgical decision making in breast cancer. [9] [10] [11] to date, no study has investigated the surgical decision-making process for rectal cancer, a condition needing similar considerations of mortality and morbidity trade-off. Data from the Cancer Care outcomes Research and surveillance (CanCoRs) study, a geographically representative study of patients with recently diagnosed rectal cancer, provide an opportunity to gain insight into patient roles, preferences, and expectations with regard to their rectal cancer care. We hypothesized that patients who underwent le would play a more active role in the decision-making process than patients who underwent tme, however, patients who underwent le would expect a surgical cure less frequently. in addition, we hypothesized that older age and higher comorbidity status would be negative predictors of active decision-making in treatment.
PATIENTS AND METHODS

Study Population and Design
CanCoRs is a geographically diverse population and healthsystem-based cohort study including 4713 adults aged ≥21 years with newly diagnosed, pathologically confirmed invasive colorectal cancer recruited between 2003 and 2005. Patients were recruited from 4 geographically based cancer registries in northern California, los angeles County (California), north Carolina, and alabama from 5 large health maintenance organizations that are part of the Cancer Research network and from 5 Veterans affairs hospitals. a recent study by Catalano et al 12 demonstrated that the CanCoRs Consortium was successful in enrolling a demographically representative sample within the CanCoRs regions with a response rate of 53.2%.
as described previously, 12 eligible patients from these sites were contacted ≈4 months after cancer diagnosis and asked to participate in a telephone survey. study participants responded within 1 to 12 months; the mean response time was 4 months after meeting initial eligibility criteria. no time limitation was allotted for survey response. interviews included questions about sociodemographic information (age, sex, education, race, marital status, and health insurance status), treatments received, providers visited, and goals, beliefs, and preferences with regard to treatment options. 13 the CanCoRs medical chart abstraction database contains detailed information on tumor characteristics and the acute treatment phase, including types of providers visited, staging procedures, and surgery, chemotherapy, and radiotherapy regimens. [12] [13] [14] medical chart information was also used to assign american Joint Committee on Cancer collaborative stage 15 and to determine adult Comorbidity evaluation-27 16 comorbidity indicators. each patient who discussed surgery, radiation, or chemotherapy with a physician was asked to report his or her actual role and preferred role in the decision by using a modified version of the validated Control Preferences Scale, 17 designed to be administered by telephone. for actual and preferred roles, the first 2 responses were categorized as patient controlled, the third was considered patient-physician shared, and the last 2 were categorized as physician-controlled decision making. figures 1 and 2 provide the response options for these survey questions. in all of the analyses, actual and preferred roles were categorized as patient-controlled (responses 1 or 2), shared (response 3), or physician-controlled roles (responses 4 or 5), as described previously. 9, 18 to identify current depression, a score of 6 or more symptoms on the 8-item Center for epidemiological studies-Depression scale was used. 19 Data Analysis the sample consisted of patients with stage i adenocarcinoma of the rectum. stage was based on a hierarchy of best available evidence, with collaborative stage (calculated american Joint Committee on Cancer stage based on medical chart abstracted tumor size, extension, lymph nodes, and metastases) at the top of the hierarchy.
Patients were divided into 2 groups based on surgical treatment, including le and tme. all of the individuals with stage i rectal adenocarcinoma (n = 157) were initially included. We excluded 3 individuals because they underwent a fulguration procedure only. the main dependent variables were the role of the patient in treatment decision making, patient preferences, and patient expectations regarding treatment. Clinical, sociodemographic, and health-system factors were assessed for association with patient decision making, preference, and expectations. student t test, χ 2 , and fisher exact tests were used to compare the groups on key variables obtained from the Can-CoRs survey and medical chart abstraction database. fisher exact tests were used when sample size was less than 5. multivariate analysis was not used to examine patient characteristics associated with surgical treatment because of the small sample size. all of the statistical analysis was performed in sas versions 9.3 (sas institute inc, Cary, nC). institutional review board exemption was obtained from the university of north Carolina institutional Review Board.
RESULTS
a total of 154 patients met the inclusion criteria. there were 122 patients who underwent tme and 32 patients who were treated with le for stage i rectal cancer. a total of 24% of patients who underwent tme and 31% of patients who underwent le received either neoadjuvant or adjuvant chemoradiotherapy.
the characteristics of the 2 study groups are displayed in table 1. Compared with the tme group, the le group was more likely to be white, have moderate/severe comorbidities, and have a Bmi ≥30. nonetheless, both groups had a similar self-reported health rating at the time of diagnosis.
the characteristics of the study population by actual decision-making roles are displayed in table 2. the actual role of the patient in surgical decision making was unavailable for 32 patients (19% (n = 23) tme vs 28% (n = 9) patients who underwent le; p = 0.25). Compared with patients aged <65 years, a nearly significantly smaller percentage of older patients (≥65 years) reported that they made decisions independently (33% vs 50%); conversely, a larger percentage of older patients reported relying on physicians to control the decision making (10% vs 3%) regarding their surgical care (p = 0.08). also, a larger percentage of individuals with higher education re-
Patient Controlled
Shared Physician-Patient Physician Controlled ""Which statement best describes the role you would prefer to play when decisions about treatment for your rectal cancer are made ?"
"You prefer to make decisions about treatment with little or no input from your doctors." "You prefer that you and your doctors make the decisions together." "You prefer that your doctors make the decisions after considering your opinion." "You prefer your doctors make the decision with little or no input from you."
"You prefer to make the decisions after considering your doctor's opinion." "You and your doctors made the decision together?"
• "Your doctors made the decision after considering your opinion."
• "Your doctors made the decision with little or no input from you."
• "You made the decision after considering your doctors' opinions." ported making patient-controlled decisions, but the difference did not reach statistical significance (48% vs 33%; p = 0.26). Patient role, beliefs regarding treatment, and treatment preferences are displayed by surgery type in table 3. for both groups, preferences regarding goals of treatment were similar; equal numbers wanted treatment that extends life as much as possible as compared with treatment that focuses on relieving pain. Yet, there was discordance between patient-reported preferred and actual roles in treatment decision making ( fig. 3) . When asked about their preferred role in decision making, 28% of patients who underwent tme preferred patient-controlled decision making com-pared with 48% of patients who underwent le (p = 0.046). however, with regard to the treatment actually received, 38% of the tme group reported making their own surgical decision compared with 25% of the le group (p = 0.18).
Concerning patient beliefs, those who underwent le were less likely than patients who underwent tme to report that surgery "would likely cure their cancer" (63% vs 80%; p = 0.04). interestingly, for all of the patients who visited a radiation oncologist, the le group was more likely to report that radiation would cure their cancer compared with the tme group (63% vs 27%; p = 0.004). this difference in curative expectations was unchanged when comparing only patients who received radiation treatment. Regarding sensitivity analysis, when we excluded older individuals (≥80 years old) and individuals with severe comorbidities, our key dependent variables did not change, which were patient-preferred and actual decision-making roles. on subgroup analysis, when asked about preferred decision-making role, 29% of patients who underwent tme preferred patient-controlled decision making compared with 47% of patients who underwent le (p = 0.02). With regard to the treatment actually received, 37% of the tme group reported making their own surgical decision compared with 21% of the le group (p = 0.15).
DISCUSSION
there are an increasing number of treatment options for patients with early stage rectal cancer. Very little is currently known about how physicians and patients decide on the best treatment options for the patient. this study sought to address this gap in our understanding and is among the first to explore surgical decision making for rectal cancer treatment. We focused on the contrast between le and proctectomy, because studies have shown that transanal procedures are increasingly used in the treatment of rectal cancer. 1, 19 in this population-based study of patients with stage i rectal cancer, there was a discrepancy between the reported preferred decision-making role regarding surgical treatment and the reported actual decision-making role. Patients who underwent LE stated more frequently that they preferred to control the decision-making process; however, this did not occur as frequently in practice.
untangling discrepancies between preferred and reported patient decision making is challenging, because studies are limited. 20 Previous studies focused on breast cancer have found that matching patients' preferred and actual roles increased patient satisfaction. 21, 22 Whether previous work in breast cancer is generalizable to patients with colorectal cancer is unclear. 23 an older study that measured preferred treatment decision making in patients with colorectal cancer found that the majority wanted to have a passive role in decision making. 24 however, this is in stark contrast to our findings, where the majority of patients preferred collaborative or active decision-making roles. We suspect that this difference is attributed to a cultural shift in patient expectations regarding their role in care over time. although we found a discrepancy between reported preferred and actual decision-making roles, we did not find a difference in patient satisfaction with surgical care based on matched decision-making roles (results not shown). Baseline patient characteristics may affect the surgical treatment offered to patients or selected. older patients and those with more comorbidities may be steered away from tme. for this study, we did a sensitivity analysis excluding the oldest and sickest patients. however, excluding these 2 groups did not influence the results for patient preferred and actual roles in the decision-making process. health literacy may also be an important factor in treatment decision making. 20 We did not find any difference in surgical treatment by education. in addition, although our study was unable to measure patient knowledge of specific treatment options, the le group reported less frequently that surgery would cure their cancer than the tme group, which provides some indication that patients understood the trade-off of tme versus le. at the same time, patients who underwent le were more likely to report radiotherapy as curative, which is inconsistent with medical teaching. interestingly, a previous study showed patients more often reported the last treatment received as the curative treatment. 25 although we were unable to assess the effects of temporality on patient perception of a treatment's curative intent, this factor may have influenced our results.
We acknowledge that there are many challenges to shared decision making with patients and in many cases this goal may be unrealistic. often it is not possible to fully inform patients who come in with limited knowledge about the treatment options yet have to make decisions that have major consequences. furthermore, these difficult decisions are made at a time when patients are stressed with a new diagnosis of cancer and have only a short amount of time to review options with clinicians whom they have likely just met. Respecting patient preferences for control or involvement in clinical decisions while balancing our professional responsibility to use our expertise is one of the great challenges in clinical medicine today. 26 however, matching preferred with actual roles is important and will become increasingly relevant as we move toward more value-based care models and incentives based on outcomes, including patientreported outcomes. 27 the strengths of this study include factors that are inherent to CanCoRs. the study cohort consisted of a population-based group of patients with rectal cancer from various geographic areas in the united states and a robust set of variables, including information about decision making, clinical factors including stage of disease, and follow-up data. unfortunately, although CanCoRs represented the largest existing population-based collection of incident colorectal cancer cases, the sample size is small because of the relative infrequency of early stage rectal cancer. this limited the ability to examine the impact of sociodemographic factors on preferred and actual decision-making roles. in addition, the response rate for this survey varied by question asked (range, 68%-94%). We do not know if the experiences of the respondents are representative of the experiences of the nonrespondents, so there is potential for nonresponse bias. this self-reported information may have been collected at any point within 4 months of diagnosis. Patient perceptions of the role that they played in decision making may evolve over that time period, resulting in recall bias. 22 Patient perception about what they desired as a role or what role they actually played could be influenced by their experience with the treatment and morbidity or adverse effects that they could be experiencing. there were a large number of patients with stage i rectal cancer receiving adjuvant therapy for a stage of disease traditionally treated by surgery only. it is possible that some of these patients were understaged by CanCoRs. however, excluding patients with neoadjuvant therapy did not significantly change our results (data not shown). lastly and probably most importantly, we do not know what information was presented to patients with regard to options and provider recommendations for care. 21 to further our understanding of patient decision making, future work should focus on how sociodemographic factors, such as sex and age, influence the decision-making role preference for this patient group. in addition, future investigations should examine how surgeon-patient interactions may best foster patient understanding of the risks and benefits of treatment options.
CONCLUSION
this study reveals that there is a mismatch between the reported preferred and actual decision making roles of patients for early stage rectal cancer. matching roles in the decision-making process will add value to patient care received. Yet, for complex decisions like the surgical treatment of early stage rectal cancer, providers must make sure that patients are fully informed of the trade-offs of treatment options so that we can empower each patient to make the best decisions possible. 
